Skip to main content
  • Saved

made a Post

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors

Source :

https://link.springer.com/article/10.1186/s40364-020-00209-0

Although the clinical development of immune checkpoint inhibitors (ICIs) therapy has ushered in a new era of anti-tumor therapy, with sustained responses and significant survival advantages observed in multiple tumors, most patients do not benefit.